April 2004
Worldwide Biotech;Apr2004, Vol. 16 Issue 4, p2
Trade Publication
Reports on the license agreement signed by Sangtec Molecular Diagnostics AB with DxS Ltd. for Scorpions technology, a proprietary nucleic acid detection and genotyping system developed by DxS. Terms of the agreement; Features of the Scorpions technology; Background of DxS.


Related Articles

  • DxS signs deal with Wellcome for research cancer mutation test.  // Medical Device Daily;9/3/2008, Vol. 12 Issue 189, p11 

    The article reports on a non-exclusive global licensing agreement signed by DxS with Wellcome Trust to use the research test developed by DxS to determine the presence of V600E B-RAF mutation in melanomas, lung and thyroid cancers. The test will be used to detect a patient's cancer mutation...

  • U. of Akron research draws licensing deal. Robinson, Ruthann // Crain's Cleveland Business;5/13/2002, Vol. 23 Issue 19, p5 

    Reports the license agreement between CathNet-Science and the University of Akron Research Foundation for the nitric oxide-releasing compound. Biotechnology to help speed the healing process among heart patients; Terms of the agreement; Number of technology-transfer licensing agreement...

  • PSMA LICENSES ALPHAVAX ARV FOR PROSTATE CANCER VACCINE.  // Biotech Business;Oct2001, Vol. 14 Issue 10, p1 

    Reports the licensing agreement between PSMA Development Co. LLC, Cytogen Corp. and AlphaVax Human Vaccines Inc. for the creation of a prostate cancer vaccine using the AlphaVax Replicon Vector system.

  • A Pilot Survey on the Licensing of DNA Inventions. Henry, Michelle R.; Cho, Mildred K.; Weaver, Meredith A.; Merz, Jon F. // Journal of Law, Medicine & Ethics;Fall2003, Vol. 31 Issue 3, p442 

    Reports on the results of pilot survey on licensing of DNA interventions. Patenting strategies; Licensing practices; Difficult issues in licensing negotiations.

  • Value drivers in licensing deals. Arnold, Katie; Coia, Anthony; Saywell, Scott; Smith, Ty; Minick, Scott; Löffler, Alicia // Nature Biotechnology;Nov2002, Vol. 20 Issue 11, p1085 

    Determines the appropriate gauge on how the value of licensing deals in commercial biotechnology is identified, enhanced and captured. Three quantitative methods used to analyze biotechnology products; Value of product deals between biotechnology and pharmaceutical companies; Impact of the type...

  • DxS signs deal with Wellcome for research cancer mutation test.  // Diagnostics & Imaging Week;9/4/2008, Vol. 11 Issue 36, p8 

    The article reports on an exclusive global licensing agreement signed by DxS with the Wellcome Trust to provide a research test for use in clinical trials to detect the presence of the V600E B-RAF mutation. Such mutation, found in melanomas, lung and thyroid cancers, was identified by scientists...

  • SEED GAMES. McMahon, Karen // Farm Industry News;Jan2005, Vol. 38 Issue 1, p4 

    Comments on the seed industry along the issues of biotechnology licensing rights and market share. Involvement of Monsanto and its Roundup Ready technology in biotech trait licensing; Formation by Monsanto of a holding company to boost its business expansion efforts.

  • The Impact of Firm and Industry Characteristics on Technology Licensing. YoungJun Kim // SAM Advanced Management Journal (07497075);Winter2005, Vol. 70 Issue 1, p42 

    This paper studies the validity of the factors that might affect the incentives of companies to license out their technology. Empirical analysis is provided with the help of a unique panel data set describing licensing arrangements in publicly traded companies in the U.S. Specifically, the...

  • Beware the traps in technology licensing. Getman, George J.; Carroll, Darren J. // Business Journal Serving Southern Tier, CNY, Mohawk Valley, Fing;5/30/94, Vol. 10 Issue 11, p9A 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics